Cramer's MAD MONEY (Oct. 23, 2006)
Cramer last night was discussing looking youthful.
Cramer called Bare Escentuals (BARE) a fad that isn't going anywhere and he thinks if you own it you should ring the register. It was spun off by an LBO firm, but the company now won't make you money. He said he didn't tell a caller on Friday to sell, and he wished he did.
Cramer likes Allergan (AGN) for Botox and Medicis (MRX) for its competing product. Cramer likes both names there. Cramer says he wouldn't even go after Avon (AVP), Estee Lauder (EL) or Revlon (REV). Cosmetic companies are unreliable to Cramer.
He did say International Flavors & Fragrances (IFF) is actually good, even though it is close to a 52-week high. He thinks they are much better with scents and steady end markets. Soon it will split into 2 businesses as it creates sweet ingrediants that it sells to large companies like P&G. He said IFF only trades at 16 times forward earnings and it has consistent 10% earnings growth. He says IFF is the best pick.
Jon C. Ogg
Cramer called Bare Escentuals (BARE) a fad that isn't going anywhere and he thinks if you own it you should ring the register. It was spun off by an LBO firm, but the company now won't make you money. He said he didn't tell a caller on Friday to sell, and he wished he did.
Cramer likes Allergan (AGN) for Botox and Medicis (MRX) for its competing product. Cramer likes both names there. Cramer says he wouldn't even go after Avon (AVP), Estee Lauder (EL) or Revlon (REV). Cosmetic companies are unreliable to Cramer.
He did say International Flavors & Fragrances (IFF) is actually good, even though it is close to a 52-week high. He thinks they are much better with scents and steady end markets. Soon it will split into 2 businesses as it creates sweet ingrediants that it sells to large companies like P&G. He said IFF only trades at 16 times forward earnings and it has consistent 10% earnings growth. He says IFF is the best pick.
Jon C. Ogg
posted by douglas mcintyre at 4:25 AM
Subscribe
<< Home